Is Takotsubo syndrome in patients receiving chemotherapy drug-specific?  

作　　者：John E Madias 

机构地区：[1]Icahn School of Medicine at Mount Sinai [2]Division of Cardiology,Elmhurst Hospital Center

出　　处：《World Journal of Clinical Cases》2015年第2期204-205,共2页世界临床病例杂志

摘　　要：In commenting on a case report of a 55-year-old man who suffered Takotsubo syndrome(TTS), in the setting of receiving chemotherapy with cytarabine and daunorubicin for acute myeloid leukemia, the author expresses his views that TTS in the setting of chemotherapy for malignancies may not be chemotherapeutic drug-specific(like in the chemotherapeutic drug induced-cardiomyopathy), but may be due to the emotional and physical stresses resulting from the realization of having diagnosed with a malignancy, and the diagnostic testing, and therapeutic management which follows.In commenting on a case report of a 55-year-old man who suffered Takotsubo syndrome(TTS), in the setting of receiving chemotherapy with cytarabine and daunorubicin for acute myeloid leukemia, the author expresses his views that TTS in the setting of chemotherapy for malignancies may not be chemotherapeutic drug-specific(like in the chemotherapeutic drug induced-cardiomyopathy), but may be due to the emotional and physical stresses resulting from the realization of having diagnosed with a malignancy, and the diagnostic testing, and therapeutic management which follows.

关 键 词：DAUNORUBICIN Radiotherapy CARDIOTOXICITY TAKOTSUBO syndrome Malignancies CHEMOTHERAPY CYTARABINE ANTHRACYCLINES Cardiomyopathy Autonomic sympathetic Nervous system 

分 类 号：R733.71[医药卫生—肿瘤] R542.2[医药卫生—临床医学]